Problem solving for tumor immunotherapy.
Gouttefangeas
C
C
Rammensee
H G
HG
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D018528:ATP-Binding Cassette Transporters / Q000235:genetics / Q000627:therapeutic use; D000818:Animals; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D004247:DNA / Q000627:therapeutic use; D007167:Immunotherapy; D051379:Mice; D009097:Multienzyme Complexes / Q000235:genetics / Q000627:therapeutic use; D009374:Neoplasms, Experimental / Q000628:therapy*; D046988:Proteasome Endopeptidase Complex; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019139:Tumor Escape / Q000276:immunology
D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D018528:ATP-Binding Cassette Transporters; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D009097:Multienzyme Complexes; C073119:TAP1 protein, human; C486171:Tap1 protein, mouse; D004247:DNA; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex